@article{a4076be19d644508bac2d7022e36ad99,
title = "Down-titration of adalimumab and etanercept in psoriatic patients: A multicentre observational study",
abstract = "N/A",
keywords = "2708, Adalimumab, Adult, Aged, Anti-Inflammatory Agents, Dermatologic Agents, Etanercept, Female, Humans, Italy, Male, Middle Aged, Psoriasis, Recurrence, Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha, 2708, Adalimumab, Adult, Aged, Anti-Inflammatory Agents, Dermatologic Agents, Etanercept, Female, Humans, Italy, Male, Middle Aged, Psoriasis, Recurrence, Remission Induction, Retrospective Studies, Risk Factors, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha",
author = "Stefano Piaserico and Paolo Gisondi and \{De Simone\}, Clara and Elena Marinello and Andrea Conti and Paolo Amerio and Andrea Peserico",
year = "2016",
doi = "10.2340/00015555-2209",
language = "English",
volume = "96",
pages = "251--252",
journal = "Acta Dermato-Venereologica",
issn = "0001-5555",
publisher = "Medical Journals Sweden AB",
number = "2",
}